Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 6/20 | 0.39 |
| ▸ | ADH1B | P00325 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.39 |
| ▸ | ADH1A | P07327 | 1/20 | 0.39 |
| ▸ | ADH4 | P08319 | 1/20 | 0.39 |
| ▸ | ADH7 | P40394 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | LPAR1 | Q92633 | 3/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.33 |
| ▸ | CNR1 | P21554 | 1/20 | 0.33 |
| ▸ | CNR2 | P34972 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9013910 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL10908778 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL8992572 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL10908837 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL9013892 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL8992562 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL8992533 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL10952012 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL10951735 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR | |
| SCHEMBL8992553 | 0.89 | DNM1 (0.46) | DNM1EPHX1ALDH1A1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7786209-B2 | Nanostructured particles, phase change inks including same and methods for making same | XEROX CORPORATION (US) | 2010-08-31 | — | — | US | claimed |
| US-20080103250-A1 | NANOSTRUCTED PARTICLES, PHASE CHANGE INKS INCLUDING SAME AND METHODS FOR MAKING SAME | XEROX CORPORATION (US) | 2008-05-01 | — | — | US | claimed |
| EP-1918294-B1 | Nanostructured Particles, Phase Change Inks Including Same and Methods for Making Same | XEROX CORP (US) | 2011-08-31 | — | — | EP | disclosed |
| US-7786209-B2 | Nanostructured particles, phase change inks including same and methods for making same | XEROX CORPORATION (US) | 2010-08-31 | — | — | US | disclosed |
| EP-1918294-A1 | Nanostructured Particles, Phase Change Inks Including Same and Methods for Making Same | Xerox Corporation (US) | 2008-05-07 | — | — | EP | disclosed |
| US-20080103250-A1 | NANOSTRUCTED PARTICLES, PHASE CHANGE INKS INCLUDING SAME AND METHODS FOR MAKING SAME | XEROX CORPORATION (US) | 2008-05-01 | — | — | US | disclosed |